Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-013055
Filing Date
2019-04-25
Accepted
2019-04-25 16:16:28
Documents
43
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20190331.htm 10-Q 825857
2 EX-31.1 mnov-ex311_9.htm EX-31.1 11003
3 EX-31.2 mnov-ex312_6.htm EX-31.2 10905
4 EX-32.1 mnov-ex321_7.htm EX-32.1 7880
5 EX-32.2 mnov-ex322_8.htm EX-32.2 7806
  Complete submission text file 0001564590-19-013055.txt   2663479

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20190331.xml EX-101.INS 381611
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20190331.xsd EX-101.SCH 26785
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20190331_cal.xml EX-101.CAL 27409
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20190331_def.xml EX-101.DEF 76025
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20190331_lab.xml EX-101.LAB 223352
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20190331_pre.xml EX-101.PRE 161820
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 19767649
SIC: 2834 Pharmaceutical Preparations